
A comprehensive examination of what we know as fact about fenbendazole and cancer, including medical papers and evidence, practical realities, financial costs, and unknowns. Educational resources only. Always consult a licensed oncologist
| Platform | Pricing | Only free issues | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 233 | Founded | 5 months ago | Last Issue | 4 days ago |
| Active | |||||

My wife has Waldenström macroglobulinemia, which is a rare non-Hodgkin's lymphoma that affects white blood cells. Is there any data on ivermectin, mebendazole, fenbendazole, or other repurposed drugs that help with reversing...
Researchers are currently evaluating the repurposing of mebendazole as an effective alternative to vincristine for combating brain cancers. While vincristine is conventionally used in neuro-oncology, it often fails to provide meaningful sur...
Fenbendazole is a widely used parasite treatment in laboratory rodent facilities, but improper administration can cause unexpected complications. Researchers found that a diet containing both fenbendazole and supplementary vitamins signific...
Ingenious Mechnanisms
This article investigates the synergistic anticancer effects of combining fenbendazole and diisopropylamine dichloroacetate (DADA) in a mouse model using human lung cancer cells. The experiment demonstrates that admin...
The provided study investigates the potential of the common antiparasitic medication mebendazole as a novel treatment for human cancer. The authors discovered that mebendazole successfully arrests cancer cell division by disrupting internal...
Subscribers, engagement, traffic and sponsorship for Fenbendazole & Cancer.
| Subscribers | Engagement | 81 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #68 | |
| #151 |
The writers behind this newsletter.
A comprehensive examination of what we actually know about Fenbendazole and cancer, including the science, the evidence, the practical realities, and the unknowns. Everything here is for education and information only, not medical advice.
You can find recent issues that have been published by Fenbendazole & Cancer on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Fenbendazole & Cancer, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Fenbendazole & Cancer as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Fenbendazole & Cancer using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Fenbendazole & Cancer. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.